FIELD: medicine, pharmacology.
SUBSTANCE: amphotericin B used in standard therapeutic doses is dissolved in 1.0-10.0% dextran aqueous solution wherein molecular mass of dextran is 30-60 kDa and wherein dextran is irradiated preliminary by ionizing radiation (by flow of accelerated electrons or by gamma-radiation) in doses 1.0-5.0 Mrad in the ratio medicinal agent : polymer = 1:800. Invention provides reducing toxicity of amphotericin B by 1.5-2.0-fold and enhancing its curative activity. Invention can be used for reducing toxicity of low-molecular synthetic medicinal agents.
EFFECT: improved method for reducing toxicity.
2 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATING FUNGOID DISEASES | 2010 |
|
RU2430730C1 |
| METHOD OF PREPARING ISONIAZID WITH PROLONGED EFFECT | 1999 |
|
RU2143900C1 |
| PHARMACEUTICAL COMPOSITION ELICITING THROMBOLYTIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE PROPERTIES | 2001 |
|
RU2213557C2 |
| METHOD FOR PRODUCING PROLONGED ACTION ISONIASIDE | 2000 |
|
RU2192865C2 |
| IMMOBILISED BACILLUS LICHENIFORMIS BACTERIA PRODUCED SUBTILISIN SHOWING THROMBOLYTIC AND ANTICOAGULANT PROPERTIES | 2008 |
|
RU2416643C2 |
| ANTIBIOTIC CONJUGATE AND ANTIBACTERIAL MEDICINAL AGENT BASED ON SAID CONJUGATE | 2007 |
|
RU2371447C2 |
| METHOD FOR IMMOBILISING BIOLOGICALLY ACTIVE SUBSTANCE (BAS) ON CARRIER (VERSIONS) AND BAS-CARRIER CONJUGATE PRODUCED BY SUCH METHODS | 2008 |
|
RU2409669C9 |
| PHARMACEUTICAL COMPOSITION SHOWING PROLONGED ANTITUBERCULOSIS EFFECT | 1999 |
|
RU2169565C1 |
| METHOD OF MEDICINAL AGENT BIOAVAILABILITY INCREASE | 2006 |
|
RU2328309C1 |
| PHARMACEUTICAL COMPOSITION, POSSESSING ANTICOAGULANT AND CHOLESTEROL-LOWERING PROPERTIES | 2007 |
|
RU2414907C2 |
